David Robertson to Growth Differentiation Factor 9
This is a "connection" page, showing publications David Robertson has written about Growth Differentiation Factor 9.
Connection Strength
0.709
-
Riepsamen AH, Donoghoe MW, Baerwald A, Pankhurst MW, Lien S, Chong YH, Robertson DM, Ledger WL, Gilchrist RB. Exploratory analysis of serum concentrations of oocyte biomarkers growth differentiation factor 9 and bone morphogenetic protein 15 in ovulatory women across the menstrual cycle. Fertil Steril. 2021 08; 116(2):546-557.
Score: 0.180
-
Riepsamen AH, Chan K, Lien S, Sweeten P, Donoghoe MW, Walker G, Fraison EHJ, Stocker WA, Walton KL, Harrison CA, Ledger WL, Robertson DM, Gilchrist RB. Serum Concentrations of Oocyte-Secreted Factors BMP15 and GDF9 During IVF and in Women With Reproductive Pathologies. Endocrinology. 2019 10 01; 160(10):2298-2313.
Score: 0.162
-
Richani D, Constance K, Lien S, Agapiou D, Stocker WA, Hedger MP, Ledger WL, Thompson JG, Robertson DM, Mottershead DG, Walton KL, Harrison CA, Gilchrist RB. Cumulin and FSH Cooperate to Regulate Inhibin B and Activin B Production by Human Granulosa-Lutein Cells In Vitro. Endocrinology. 2019 04 01; 160(4):853-862.
Score: 0.157
-
Simpson CM, Robertson DM, Al-Musawi SL, Heath DA, McNatty KP, Ritter LJ, Mottershead DG, Gilchrist RB, Harrison CA, Stanton PG. Aberrant GDF9 expression and activation are associated with common human ovarian disorders. J Clin Endocrinol Metab. 2014 Apr; 99(4):E615-24.
Score: 0.109
-
Riepsamen AH, Donoghoe MW, Indran IR, Hechtman L, Robertson DM, Gilchrist RB, Ledger WL, Yong EL. Serum GDF9 and BMP15 as potential markers of ovarian function in women with and without polycystic ovary syndrome. Clin Endocrinol (Oxf). 2023 04; 98(4):567-577.
Score: 0.051
-
Shamsa A, Gilchrist RB, Robertson DM, Rodgers RJ, Donoghoe MW, Ledger WL, Abbott JA, Riepsamen AH. Oocyte-Secreted Serum Biomarkers GDF9 and BMP15 in Women with Endometriosis. Reprod Sci. 2023 05; 30(5):1521-1527.
Score: 0.050